Skip to main content
Erschienen in: Journal of Neurology 7/2016

02.01.2016 | Review

Multiple sclerosis in men: management considerations

verfasst von: Riley Bove, Allison McHenry, Kerstin Hellwig, Maria Houtchens, Neda Razaz, Penelope Smyth, Helen Tremlett, A. D. Sadovnick, D. Rintell

Erschienen in: Journal of Neurology | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Multiple sclerosis (MS) is a lifelong disease typically affecting individuals in young to middle adulthood. There are recognized sex differences in MS onset and clinical course. MS affects approximately three times more women than men, thus resulting in less attention to the male experience (i.e. diagnosis, management, societal dimensions). Here, we review current scientific evidence on sex differences in MS risk and course, highlight potential sources of bias, and suggest avenues of further inquiry. We then describe what is known about male experiences with MS diagnosis, treatment, and symptom management (particularly mood and sexual function). Finally, we consider ways in which healthcare providers might engage male patients in the broader aspects of living with MS (e.g. familial and societal relationships) to influence their long-term quality of life (QOL). When possible, we draw from published sources to underscore our collective clinical and scientific experiences.
Literatur
1.
Zurück zum Zitat Carlson NR, Buskist W, Heth DC, Schmaltz R (eds) (2009) Psychology: the science of behavior, 4th edn. Pearson Education Canada, Toronto Carlson NR, Buskist W, Heth DC, Schmaltz R (eds) (2009) Psychology: the science of behavior, 4th edn. Pearson Education Canada, Toronto
2.
Zurück zum Zitat Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD et al (2006) Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol [Comparative Study Research Support, Non-U.S. Gov’t] 5(11):932–936 Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD et al (2006) Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol [Comparative Study Research Support, Non-U.S. Gov’t] 5(11):932–936
3.
Zurück zum Zitat Trojano M, Lucchese G, Graziano G, Taylor BV, Simpson S Jr, Lepore V et al (2012) Geographical variations in sex ratio trends over time in multiple sclerosis. PLoS ONE [Research Support, Non-U.S. Gov’t] 7(10):e48078 Trojano M, Lucchese G, Graziano G, Taylor BV, Simpson S Jr, Lepore V et al (2012) Geographical variations in sex ratio trends over time in multiple sclerosis. PLoS ONE [Research Support, Non-U.S. Gov’t] 7(10):e48078
4.
Zurück zum Zitat Borisow N, Doring A, Pfueller CF, Paul F, Dorr J, Hellwig K (2012) Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy. Epma J. 3(1):9PubMedPubMedCentralCrossRef Borisow N, Doring A, Pfueller CF, Paul F, Dorr J, Hellwig K (2012) Expert recommendations to personalization of medical approaches in treatment of multiple sclerosis: an overview of family planning and pregnancy. Epma J. 3(1):9PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat McCombe PA, Greer JM (2013) Female reproductive issues in multiple sclerosis. Mult Scler [Research Support, Non-U.S. Gov’t] 19(4):392–402 McCombe PA, Greer JM (2013) Female reproductive issues in multiple sclerosis. Mult Scler [Research Support, Non-U.S. Gov’t] 19(4):392–402
7.
Zurück zum Zitat Bodiguel E, Bensa C, Brassat D, Laplaud D, Le Page E, Ouallet JC et al (2014) Multiple sclerosis and pregnancy. Rev Neurol (Paris) [Research Support, Non-U.S. Gov’t] 170(4):247–265CrossRef Bodiguel E, Bensa C, Brassat D, Laplaud D, Le Page E, Ouallet JC et al (2014) Multiple sclerosis and pregnancy. Rev Neurol (Paris) [Research Support, Non-U.S. Gov’t] 170(4):247–265CrossRef
8.
Zurück zum Zitat Bove R, Chitnis T (2014) The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis. Mult Scler. 20(5):520–526PubMedCrossRef Bove R, Chitnis T (2014) The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis. Mult Scler. 20(5):520–526PubMedCrossRef
9.
Zurück zum Zitat Bove R, Alwan S, Friedman JM, Hellwig K, Houtchens M, Koren G et al (2014) Management of multiple sclerosis during pregnancy and the reproductive years: a systematic review. Obstet Gynecol [Research Support, Non-U.S. Gov’t Review] 124(6):1157–1168 Bove R, Alwan S, Friedman JM, Hellwig K, Houtchens M, Koren G et al (2014) Management of multiple sclerosis during pregnancy and the reproductive years: a systematic review. Obstet Gynecol [Research Support, Non-U.S. Gov’t Review] 124(6):1157–1168
10.
Zurück zum Zitat Maghzi AH, Ghazavi H, Ahsan M, Etemadifar M, Mousavi S, Khorvash F et al (2010) Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study. Mult Scler 16(3):359–361PubMedCrossRef Maghzi AH, Ghazavi H, Ahsan M, Etemadifar M, Mousavi S, Khorvash F et al (2010) Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study. Mult Scler 16(3):359–361PubMedCrossRef
11.
12.
Zurück zum Zitat Paty DW, Noseworthy JH, Ebers GC (1997) Diagnosis of multiple sclerosis. In: Paty DW, Ebers GC (eds) Multiple sclerosis. FA Davis Company, Philadelphia, pp 48–51 Paty DW, Noseworthy JH, Ebers GC (1997) Diagnosis of multiple sclerosis. In: Paty DW, Ebers GC (eds) Multiple sclerosis. FA Davis Company, Philadelphia, pp 48–51
13.
Zurück zum Zitat Compston A, Confavreaux C, Lassmann H, McDonald I, Miller D, Noseworthy J, Smith K, Wekerle H (2006) The natural history of multiple sclerosis. In: McAlpine’s multiple sclerosis, 4th edn. Churchill Livingstone Elsevier, pp 183–272 Compston A, Confavreaux C, Lassmann H, McDonald I, Miller D, Noseworthy J, Smith K, Wekerle H (2006) The natural history of multiple sclerosis. In: McAlpine’s multiple sclerosis, 4th edn. Churchill Livingstone Elsevier, pp 183–272
14.
Zurück zum Zitat Tremlett H, Zhao Y, Joseph J, Devonshire V (2008) Relapses in multiple sclerosis are age- and time-dependent. J Neurol Neurosurg Psychiatry [Research Support, Non-U.S. Gov’t] 79(12):1368–1374CrossRef Tremlett H, Zhao Y, Joseph J, Devonshire V (2008) Relapses in multiple sclerosis are age- and time-dependent. J Neurol Neurosurg Psychiatry [Research Support, Non-U.S. Gov’t] 79(12):1368–1374CrossRef
15.
Zurück zum Zitat van Wijk CM, Kolk AM (1997) Sex differences in physical symptoms: the contribution of symptom perception theory. Soc Sci Med 45(2):231–246PubMedCrossRef van Wijk CM, Kolk AM (1997) Sex differences in physical symptoms: the contribution of symptom perception theory. Soc Sci Med 45(2):231–246PubMedCrossRef
16.
Zurück zum Zitat Savettieri G, Messina D, Andreoli V, Bonavita S, Caltagirone C, Cittadella R et al (2004) Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J Neurol [Comparative Study Research Support, Non-U.S. Gov’t] 251(10):1208–1214 Savettieri G, Messina D, Andreoli V, Bonavita S, Caltagirone C, Cittadella R et al (2004) Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis. J Neurol [Comparative Study Research Support, Non-U.S. Gov’t] 251(10):1208–1214
17.
Zurück zum Zitat Benedict RH, Zivadinov R (2011) Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol [Review] 7(6):332–342CrossRef Benedict RH, Zivadinov R (2011) Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol [Review] 7(6):332–342CrossRef
18.
Zurück zum Zitat Koch M, Kingwell E, Rieckmann P, Tremlett H (2010) The natural history of secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry [Research Support, Non-U.S. Gov’t] 81(9):1039–1043CrossRef Koch M, Kingwell E, Rieckmann P, Tremlett H (2010) The natural history of secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry [Research Support, Non-U.S. Gov’t] 81(9):1039–1043CrossRef
19.
Zurück zum Zitat Bove RM, Healy B, Augustine A, Musallam A, Gholipour T, Chitnis T (2012) Effect of gender on late-onset multiple sclerosis. Mult Scler [Research Support, Non-U.S. Gov’t] 18(10):1472–1479 Bove RM, Healy B, Augustine A, Musallam A, Gholipour T, Chitnis T (2012) Effect of gender on late-onset multiple sclerosis. Mult Scler [Research Support, Non-U.S. Gov’t] 18(10):1472–1479
20.
Zurück zum Zitat Ribbons KA, McElduff P, Boz C, Trojano M, Izquierdo G, Duquette P et al (2015) Male sex is independently associated with faster disability accumulation in relapse-onset ms but not in primary progressive MS. PLoS ONE 10(6):e0122686PubMedPubMedCentralCrossRef Ribbons KA, McElduff P, Boz C, Trojano M, Izquierdo G, Duquette P et al (2015) Male sex is independently associated with faster disability accumulation in relapse-onset ms but not in primary progressive MS. PLoS ONE 10(6):e0122686PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Tremlett H, Paty D, Devonshire V (2006) Disability progression in multiple sclerosis is slower than previously reported. Neurology [Research Support, Non-U.S. Gov’t] 66(2):172–177 Tremlett H, Paty D, Devonshire V (2006) Disability progression in multiple sclerosis is slower than previously reported. Neurology [Research Support, Non-U.S. Gov’t] 66(2):172–177
22.
Zurück zum Zitat Bove R, Musallam A, Healy BC, Houtchens M, Glanz BI, Khoury S et al (2013) No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50. BMC Neurol [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t] 13:73 Bove R, Musallam A, Healy BC, Houtchens M, Glanz BI, Khoury S et al (2013) No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50. BMC Neurol [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t] 13:73
23.
Zurück zum Zitat Schoonheim MM, Hulst HE, Landi D, Ciccarelli O, Roosendaal SD, Sanz-Arigita EJ et al (2012) Gender-related differences in functional connectivity in multiple sclerosis. Mult Scler [Comparative Study Research Support, Non-U.S. Gov’t] 18(2):164–173 Schoonheim MM, Hulst HE, Landi D, Ciccarelli O, Roosendaal SD, Sanz-Arigita EJ et al (2012) Gender-related differences in functional connectivity in multiple sclerosis. Mult Scler [Comparative Study Research Support, Non-U.S. Gov’t] 18(2):164–173
24.
Zurück zum Zitat Schoonheim MM, Popescu V, Rueda Lopes FC, Wiebenga OT, Vrenken H, Douw L et al (2012) Subcortical atrophy and cognition: sex effects in multiple sclerosis. Neurology 79(17):1754–1761PubMedCrossRef Schoonheim MM, Popescu V, Rueda Lopes FC, Wiebenga OT, Vrenken H, Douw L et al (2012) Subcortical atrophy and cognition: sex effects in multiple sclerosis. Neurology 79(17):1754–1761PubMedCrossRef
25.
Zurück zum Zitat Schoonheim MM, Vigeveno RM, Lopes FC, Pouwels PJ, Polman CH, Barkhof F et al (2014) Sex-specific extent and severity of white matter damage in multiple sclerosis: implications for cognitive decline. Hum Brain Mapp 35(5):2348–2358. doi:10.1002/hbm.22332 PubMedCrossRef Schoonheim MM, Vigeveno RM, Lopes FC, Pouwels PJ, Polman CH, Barkhof F et al (2014) Sex-specific extent and severity of white matter damage in multiple sclerosis: implications for cognitive decline. Hum Brain Mapp 35(5):2348–2358. doi:10.​1002/​hbm.​22332 PubMedCrossRef
26.
Zurück zum Zitat Pozzilli C, Tomassini V, Marinelli F, Paolillo A, Gasperini C, Bastianello S (2003) ‘Gender gap’ in multiple sclerosis: magnetic resonance imaging evidence. Eur J Neurol [Comparative Study] 10(1):95–97CrossRef Pozzilli C, Tomassini V, Marinelli F, Paolillo A, Gasperini C, Bastianello S (2003) ‘Gender gap’ in multiple sclerosis: magnetic resonance imaging evidence. Eur J Neurol [Comparative Study] 10(1):95–97CrossRef
27.
Zurück zum Zitat Kingwell E, van der Kop M, Zhao Y, Shirani A, Zhu F, Oger J et al (2012) Relative mortality and survival in multiple sclerosis: findings from British Columbia. Canada. J Neurol Neurosurg Psychiatry [Research Support, Non-U.S. Gov’t] 83(1):61–66CrossRef Kingwell E, van der Kop M, Zhao Y, Shirani A, Zhu F, Oger J et al (2012) Relative mortality and survival in multiple sclerosis: findings from British Columbia. Canada. J Neurol Neurosurg Psychiatry [Research Support, Non-U.S. Gov’t] 83(1):61–66CrossRef
28.
Zurück zum Zitat Ramagopalan SV, Valdar W, Dyment DA, DeLuca GC, Yee IM, Giovannoni G et al (2009) Association of infectious mononucleosis with multiple sclerosis. A population-based study. Neuroepidemiology. 32(4):257–262PubMed Ramagopalan SV, Valdar W, Dyment DA, DeLuca GC, Yee IM, Giovannoni G et al (2009) Association of infectious mononucleosis with multiple sclerosis. A population-based study. Neuroepidemiology. 32(4):257–262PubMed
29.
Zurück zum Zitat Hickey MS, Israel RG, Gardiner SN, Considine RV, McCammon MR, Tyndall GL et al (1996) Gender differences in serum leptin levels in humans. Biochem Mol Med [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.] 59(1):1–6 Hickey MS, Israel RG, Gardiner SN, Considine RV, McCammon MR, Tyndall GL et al (1996) Gender differences in serum leptin levels in humans. Biochem Mol Med [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.] 59(1):1–6
30.
Zurück zum Zitat Bove RM, Healy B, Augustine A, Musallam A, Gholipour T, Chitnis T (2012) Effect of gender on late-onset multiple sclerosis. Mult Scler 18(10):1472–1479PubMedCrossRef Bove RM, Healy B, Augustine A, Musallam A, Gholipour T, Chitnis T (2012) Effect of gender on late-onset multiple sclerosis. Mult Scler 18(10):1472–1479PubMedCrossRef
31.
Zurück zum Zitat Magyari M, Koch-Henriksen N, Laursen B, Sorensen PS (2014) Gender effects on treatment response to interferon-beta in multiple sclerosis. Acta Neurol Scand 130(6):374–379PubMedCrossRef Magyari M, Koch-Henriksen N, Laursen B, Sorensen PS (2014) Gender effects on treatment response to interferon-beta in multiple sclerosis. Acta Neurol Scand 130(6):374–379PubMedCrossRef
32.
Zurück zum Zitat Rudick RA, Kappos L, Kinkel R, Clanet M, Phillips JT, Herndon RM et al (2011) Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patients. Mult Scler 17(3):353–360PubMedCrossRef Rudick RA, Kappos L, Kinkel R, Clanet M, Phillips JT, Herndon RM et al (2011) Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patients. Mult Scler 17(3):353–360PubMedCrossRef
33.
Zurück zum Zitat Wolinsky JS, Shochat T, Weiss S, Ladkani D (2009) Glatiramer acetate treatment in PPMS: why males appear to respond favorably. J Neurol Sci 286(1–2):92–98PubMedCrossRef Wolinsky JS, Shochat T, Weiss S, Ladkani D (2009) Glatiramer acetate treatment in PPMS: why males appear to respond favorably. J Neurol Sci 286(1–2):92–98PubMedCrossRef
34.
Zurück zum Zitat Hutchinson M, Kappos L, Calabresi PA, Confavreux C, Giovannoni G, Galetta SL et al (2009) The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL. J Neurol 256(3):405–415PubMedCrossRef Hutchinson M, Kappos L, Calabresi PA, Confavreux C, Giovannoni G, Galetta SL et al (2009) The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL. J Neurol 256(3):405–415PubMedCrossRef
35.
Zurück zum Zitat Munger KL, Chitnis T, Ascherio A (2009) Body size and risk of MS in two cohorts of US women. Neurology [Comparative Study Research Support, N.I.H., Extramural] 73(19):1543–1550 Munger KL, Chitnis T, Ascherio A (2009) Body size and risk of MS in two cohorts of US women. Neurology [Comparative Study Research Support, N.I.H., Extramural] 73(19):1543–1550
36.
Zurück zum Zitat Kucukali CI, Kurtuncu M, Coban A, Cebi M, Tuzun E (2015) Epigenetics of multiple sclerosis: an updated review. Neuromolecular Med. 17(2):83–96PubMedCrossRef Kucukali CI, Kurtuncu M, Coban A, Cebi M, Tuzun E (2015) Epigenetics of multiple sclerosis: an updated review. Neuromolecular Med. 17(2):83–96PubMedCrossRef
37.
Zurück zum Zitat Hollenbach JA (2015) Oksenberg JR. A comprehensive review. J Autoimmun, The immunogenetics of multiple sclerosis, p 2 Hollenbach JA (2015) Oksenberg JR. A comprehensive review. J Autoimmun, The immunogenetics of multiple sclerosis, p 2
38.
Zurück zum Zitat Ramagopalan SV, Herrera BM, Bell JT, Dyment DA, Deluca GC, Lincoln MR et al (2008) Parental transmission of HLA-DRB1*15 in multiple sclerosis. Hum Genet 122(6):661–663PubMedCrossRef Ramagopalan SV, Herrera BM, Bell JT, Dyment DA, Deluca GC, Lincoln MR et al (2008) Parental transmission of HLA-DRB1*15 in multiple sclerosis. Hum Genet 122(6):661–663PubMedCrossRef
39.
Zurück zum Zitat Celius EG, Harbo HF, Egeland T, Vartdal F, Vandvik B, Spurkiand A (2000) Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis. J Neurol Sci 178(2):132–135PubMedCrossRef Celius EG, Harbo HF, Egeland T, Vartdal F, Vandvik B, Spurkiand A (2000) Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis. J Neurol Sci 178(2):132–135PubMedCrossRef
40.
Zurück zum Zitat Westerlind H, Ramanujam R, Uvehag D, Kuja-Halkola R, Boman M, Bottai M et al (2014) Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden. Brain. 137(Pt 3):770–778PubMedPubMedCentralCrossRef Westerlind H, Ramanujam R, Uvehag D, Kuja-Halkola R, Boman M, Bottai M et al (2014) Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden. Brain. 137(Pt 3):770–778PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Ritchie ME, Liu R, Carvalho BS, Irizarry RA (2011) Comparing genotyping algorithms for Illumina’s Infinium whole-genome SNP BeadChips. BMC Bioinformatics [Comparative Study Research Support, Non-U.S. Gov’t] 12:68 Ritchie ME, Liu R, Carvalho BS, Irizarry RA (2011) Comparing genotyping algorithms for Illumina’s Infinium whole-genome SNP BeadChips. BMC Bioinformatics [Comparative Study Research Support, Non-U.S. Gov’t] 12:68
42.
Zurück zum Zitat Smith-Bouvier DL, Divekar AA, Sasidhar M, Du S, Tiwari-Woodruff SK, King JK et al (2008) A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med 205(5):1099–1108PubMedPubMedCentralCrossRef Smith-Bouvier DL, Divekar AA, Sasidhar M, Du S, Tiwari-Woodruff SK, King JK et al (2008) A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med 205(5):1099–1108PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Du S, Itoh N, Askarinam S, Hill H, Arnold AP, Voskuhl RR (2014) XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 111(7):2806–2811PubMedPubMedCentralCrossRef Du S, Itoh N, Askarinam S, Hill H, Arnold AP, Voskuhl RR (2014) XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 111(7):2806–2811PubMedPubMedCentralCrossRef
44.
Zurück zum Zitat Knudsen GP (2009) Gender bias in autoimmune diseases: X chromosome inactivation in women with multiple sclerosis. J Neurol Sci [Review] 286(1–2):43–46CrossRef Knudsen GP (2009) Gender bias in autoimmune diseases: X chromosome inactivation in women with multiple sclerosis. J Neurol Sci [Review] 286(1–2):43–46CrossRef
45.
Zurück zum Zitat Spach KM, Hayes CE (2005) Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 175(6):4119–4126PubMedCrossRef Spach KM, Hayes CE (2005) Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 175(6):4119–4126PubMedCrossRef
46.
Zurück zum Zitat Munger KL, Bentzen J, Laursen B, Stenager E, Koch-Henriksen N, Sorensen TI et al (2013) Childhood body mass index and multiple sclerosis risk: a long-term cohort study. Mult Scler [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t] 19(10):1323–1329 Munger KL, Bentzen J, Laursen B, Stenager E, Koch-Henriksen N, Sorensen TI et al (2013) Childhood body mass index and multiple sclerosis risk: a long-term cohort study. Mult Scler [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t] 19(10):1323–1329
47.
Zurück zum Zitat Langer-Gould A, Brara SM, Beaber BE, Koebnick C (2013) Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome. Neurology [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t] 80(6):548–552 Langer-Gould A, Brara SM, Beaber BE, Koebnick C (2013) Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome. Neurology [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t] 80(6):548–552
48.
Zurück zum Zitat Ragnedda G, Leoni S, Parpinel M, Casetta I, Riise T, Myhr KM et al (2015) Reduced duration of breastfeeding is associated with a higher risk of multiple sclerosis in both Italian and Norwegian adult males: the EnvIMS study. J Neurol 262(5):1271–1277PubMedCrossRef Ragnedda G, Leoni S, Parpinel M, Casetta I, Riise T, Myhr KM et al (2015) Reduced duration of breastfeeding is associated with a higher risk of multiple sclerosis in both Italian and Norwegian adult males: the EnvIMS study. J Neurol 262(5):1271–1277PubMedCrossRef
49.
Zurück zum Zitat Gunnarsson M, Udumyan R, Bahmanyar S, Nilsagard Y, Montgomery S (2015) Characteristics in childhood and adolescence associated with future multiple sclerosis risk in men: cohort study. Eur J Neurol 22(7):1131–1137PubMedCrossRef Gunnarsson M, Udumyan R, Bahmanyar S, Nilsagard Y, Montgomery S (2015) Characteristics in childhood and adolescence associated with future multiple sclerosis risk in men: cohort study. Eur J Neurol 22(7):1131–1137PubMedCrossRef
50.
Zurück zum Zitat Bove R, Musallam A, Healy BC, Raghavan K, Glanz BI, Bakshi R et al (2014) Low testosterone is associated with disability in men with multiple sclerosis. Mult Scler. 20(12):1584–1592PubMedPubMedCentralCrossRef Bove R, Musallam A, Healy BC, Raghavan K, Glanz BI, Bakshi R et al (2014) Low testosterone is associated with disability in men with multiple sclerosis. Mult Scler. 20(12):1584–1592PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Pakpoor J, Goldacre R, Schmierer K, Giovannoni G, Goldacre MJ (2014) Testicular hypofunction and multiple sclerosis risk: A record-linkage study. Ann Neurol Pakpoor J, Goldacre R, Schmierer K, Giovannoni G, Goldacre MJ (2014) Testicular hypofunction and multiple sclerosis risk: A record-linkage study. Ann Neurol
52.
53.
Zurück zum Zitat Naismith RT, Trinkaus K, Cross AH (2006) Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review. Mult Scler. 12(6):775–781PubMedCrossRef Naismith RT, Trinkaus K, Cross AH (2006) Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review. Mult Scler. 12(6):775–781PubMedCrossRef
54.
Zurück zum Zitat Cree BA, Khan O, Bourdette D, Goodin DS, Cohen JA, Marrie RA et al (2004) Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology. 63(11):2039–2045PubMedCrossRef Cree BA, Khan O, Bourdette D, Goodin DS, Cohen JA, Marrie RA et al (2004) Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology. 63(11):2039–2045PubMedCrossRef
55.
Zurück zum Zitat Weinstock-Guttman B, Ramanathan M, Hashmi K, Abdelrahman N, Hojnacki D, Dwyer MG et al (2010) Increased tissue damage and lesion volumes in African Americans with multiple sclerosis. Neurology. 74(7):538–544PubMedCrossRef Weinstock-Guttman B, Ramanathan M, Hashmi K, Abdelrahman N, Hojnacki D, Dwyer MG et al (2010) Increased tissue damage and lesion volumes in African Americans with multiple sclerosis. Neurology. 74(7):538–544PubMedCrossRef
56.
Zurück zum Zitat Rubtsova K, Marrack P, Rubtsov AV (2015) Sexual dimorphism in autoimmunity. J Clin Invest [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Review] 125(6):2187–2193 Rubtsova K, Marrack P, Rubtsov AV (2015) Sexual dimorphism in autoimmunity. J Clin Invest [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Review] 125(6):2187–2193
57.
Zurück zum Zitat McCombe PA, Greer JM, Mackay IR (2009) Sexual dimorphism in autoimmune disease. Curr Mol Med [Review] 9(9):1058–1079CrossRef McCombe PA, Greer JM, Mackay IR (2009) Sexual dimorphism in autoimmune disease. Curr Mol Med [Review] 9(9):1058–1079CrossRef
58.
Zurück zum Zitat Ngo ST, Steyn FJ, McCombe PA (2014) Gender differences in autoimmune disease. Front Neuroendocrinol [Review] 35(3):347–369CrossRef Ngo ST, Steyn FJ, McCombe PA (2014) Gender differences in autoimmune disease. Front Neuroendocrinol [Review] 35(3):347–369CrossRef
59.
Zurück zum Zitat Zhang MA, Rego D, Moshkova M, Kebir H, Chruscinski A, Nguyen H et al (2012) Peroxisome proliferator-activated receptor (PPAR)alpha and -gamma regulate IFNgamma and IL-17A production by human T cells in a sex-specific way. Proc Natl Acad Sci USA 109(24):9505–9510PubMedPubMedCentralCrossRef Zhang MA, Rego D, Moshkova M, Kebir H, Chruscinski A, Nguyen H et al (2012) Peroxisome proliferator-activated receptor (PPAR)alpha and -gamma regulate IFNgamma and IL-17A production by human T cells in a sex-specific way. Proc Natl Acad Sci USA 109(24):9505–9510PubMedPubMedCentralCrossRef
60.
Zurück zum Zitat Pozzilli C, Tomassini V, Marinelli F, Paolillo A, Gasperini C, Bastianello S (2003) ‘Gender gap’ in multiple sclerosis: magnetic resonance imaging evidence. Eur J Neurol 10(1):95–97PubMedCrossRef Pozzilli C, Tomassini V, Marinelli F, Paolillo A, Gasperini C, Bastianello S (2003) ‘Gender gap’ in multiple sclerosis: magnetic resonance imaging evidence. Eur J Neurol 10(1):95–97PubMedCrossRef
61.
Zurück zum Zitat Kuhlmann T, Goldschmidt T, Antel J, Wegner C, Konig F, Metz I et al (2009) Gender differences in the histopathology of MS? J Neurol Sci 286(1–2):86–91PubMedCrossRef Kuhlmann T, Goldschmidt T, Antel J, Wegner C, Konig F, Metz I et al (2009) Gender differences in the histopathology of MS? J Neurol Sci 286(1–2):86–91PubMedCrossRef
62.
Zurück zum Zitat Owens GM (2008) Gender differences in health care expenditures, resource utilization, and quality of care. J Manag Care Pharm 14(3 Suppl):2–6PubMed Owens GM (2008) Gender differences in health care expenditures, resource utilization, and quality of care. J Manag Care Pharm 14(3 Suppl):2–6PubMed
63.
Zurück zum Zitat Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA (2000) Gender differences in the utilization of health care services. J Fam Pract 49(2):147–152PubMed Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA (2000) Gender differences in the utilization of health care services. J Fam Pract 49(2):147–152PubMed
64.
Zurück zum Zitat Tan YC, Sinclair H, Ghoorah K, Teoh X, Mehran R, Kunadian V (2015) Gender differences in outcomes in patients with acute coronary syndrome in the current era: a review. Eur Heart J Acute Cardiovasc Care [Review] Tan YC, Sinclair H, Ghoorah K, Teoh X, Mehran R, Kunadian V (2015) Gender differences in outcomes in patients with acute coronary syndrome in the current era: a review. Eur Heart J Acute Cardiovasc Care [Review]
65.
Zurück zum Zitat Schwartz L, Kraft GH (1999) The role of spouse responses to disability and family environment in multiple sclerosis. Am J Phys Med Rehabil 78(6):525–532PubMedCrossRef Schwartz L, Kraft GH (1999) The role of spouse responses to disability and family environment in multiple sclerosis. Am J Phys Med Rehabil 78(6):525–532PubMedCrossRef
67.
Zurück zum Zitat Wallin MT, Culpepper WJ, Coffman P, Pulaski S, Maloni H, Mahan CM et al (2012) The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service. Brain. 135(Pt 6):1778–1785PubMedCrossRef Wallin MT, Culpepper WJ, Coffman P, Pulaski S, Maloni H, Mahan CM et al (2012) The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service. Brain. 135(Pt 6):1778–1785PubMedCrossRef
68.
Zurück zum Zitat Marrie RA, Elliott L, Marriott J, Cossoy M, Blanchard J, Leung S et al (2015) Effect of comorbidity on mortality in multiple sclerosis. Neurology [Research Support, Non-U.S. Gov’t] 85(3):240–247 Marrie RA, Elliott L, Marriott J, Cossoy M, Blanchard J, Leung S et al (2015) Effect of comorbidity on mortality in multiple sclerosis. Neurology [Research Support, Non-U.S. Gov’t] 85(3):240–247
69.
Zurück zum Zitat Noyes K, Weinstock-Guttman B (2013) Impact of diagnosis and early treatment on the course of multiple sclerosis. Am J Manag Care [Research Support, Non-U.S. Gov’t Review] 19(17 Suppl):s321–s331 Noyes K, Weinstock-Guttman B (2013) Impact of diagnosis and early treatment on the course of multiple sclerosis. Am J Manag Care [Research Support, Non-U.S. Gov’t Review] 19(17 Suppl):s321–s331
70.
Zurück zum Zitat Cohen BA, Coyle PK, Leist T, Oleen-Burkey MA, Schwartz M, Zwibel H (2015) Therapy optimization in multiple sclerosis: a cohort study of therapy adherence and risk of relapse. Mult Scler Relat Disord. 4(1):75–82PubMedCrossRef Cohen BA, Coyle PK, Leist T, Oleen-Burkey MA, Schwartz M, Zwibel H (2015) Therapy optimization in multiple sclerosis: a cohort study of therapy adherence and risk of relapse. Mult Scler Relat Disord. 4(1):75–82PubMedCrossRef
71.
Zurück zum Zitat Tremlett HL, Oger J (2003) Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS. Neurology 61(4):551–554PubMedCrossRef Tremlett HL, Oger J (2003) Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS. Neurology 61(4):551–554PubMedCrossRef
72.
Zurück zum Zitat Fox RJ, Salter AR, Tyry T, Sun J, You X, Laforet G et al (2013) Treatment discontinuation and disease progression with injectable disease-modifying therapies: findings from the north american research committee on multiple sclerosis database. Int J MS Care. 15(4):194–201PubMedPubMedCentralCrossRef Fox RJ, Salter AR, Tyry T, Sun J, You X, Laforet G et al (2013) Treatment discontinuation and disease progression with injectable disease-modifying therapies: findings from the north american research committee on multiple sclerosis database. Int J MS Care. 15(4):194–201PubMedPubMedCentralCrossRef
73.
Zurück zum Zitat Clanet MC, Wolinsky JS, Ashton RJ, Hartung HP, Reingold SC (2014) Risk evaluation and monitoring in multiple sclerosis therapeutics. Mult Scler. 20(10):1306–1311PubMedPubMedCentralCrossRef Clanet MC, Wolinsky JS, Ashton RJ, Hartung HP, Reingold SC (2014) Risk evaluation and monitoring in multiple sclerosis therapeutics. Mult Scler. 20(10):1306–1311PubMedPubMedCentralCrossRef
74.
Zurück zum Zitat Caon C, Saunders C, Smrtka J, Baxter N, Shoemaker J (2010) Injectable disease-modifying therapy for relapsing-remitting multiple sclerosis: a review of adherence data. J Neurosci Nurs 42(5 Suppl):S5–S9PubMedCrossRef Caon C, Saunders C, Smrtka J, Baxter N, Shoemaker J (2010) Injectable disease-modifying therapy for relapsing-remitting multiple sclerosis: a review of adherence data. J Neurosci Nurs 42(5 Suppl):S5–S9PubMedCrossRef
75.
Zurück zum Zitat Jokubaitis VG, Spelman T, Lechner-Scott J, Barnett M, Shaw C, Vucic S et al (2013) The Australian multiple sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platform. PLoS ONE [Multicenter Study Research Support, Non-U.S. Gov’t] 8(3):e59694 Jokubaitis VG, Spelman T, Lechner-Scott J, Barnett M, Shaw C, Vucic S et al (2013) The Australian multiple sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platform. PLoS ONE [Multicenter Study Research Support, Non-U.S. Gov’t] 8(3):e59694
76.
Zurück zum Zitat Saunders C, Caon C, Smrtka J, Shoemaker J (2010) Factors that influence adherence and strategies to maintain adherence to injected therapies for patients with multiple sclerosis. J Neurosci Nurs 42(5 Suppl):S10–S18PubMedCrossRef Saunders C, Caon C, Smrtka J, Shoemaker J (2010) Factors that influence adherence and strategies to maintain adherence to injected therapies for patients with multiple sclerosis. J Neurosci Nurs 42(5 Suppl):S10–S18PubMedCrossRef
77.
Zurück zum Zitat Mohr DC, Cox D, Merluzzi N (2005) Self-injection anxiety training: a treatment for patients unable to self-inject injectable medications. Mult Scler. 11(2):182–185PubMedCrossRef Mohr DC, Cox D, Merluzzi N (2005) Self-injection anxiety training: a treatment for patients unable to self-inject injectable medications. Mult Scler. 11(2):182–185PubMedCrossRef
78.
Zurück zum Zitat Tarrants M, Oleen-Burkey M, Castelli-Haley J, Lage MJ (2011) The impact of comorbid depression on adherence to therapy for multiple sclerosis. Mult Scler Int. 2011:271321PubMedPubMedCentral Tarrants M, Oleen-Burkey M, Castelli-Haley J, Lage MJ (2011) The impact of comorbid depression on adherence to therapy for multiple sclerosis. Mult Scler Int. 2011:271321PubMedPubMedCentral
79.
Zurück zum Zitat Dor A, Lage MJ, Tarrants ML, Castelli-Haley J (2010) Cost sharing, benefit design, and adherence: the case of multiple sclerosis. Adv Health Econ Health Serv Res. 22:175–193PubMedCrossRef Dor A, Lage MJ, Tarrants ML, Castelli-Haley J (2010) Cost sharing, benefit design, and adherence: the case of multiple sclerosis. Adv Health Econ Health Serv Res. 22:175–193PubMedCrossRef
80.
Zurück zum Zitat Grytten N, Aarseth JH, Espeset K, Johnsen GB, Wehus R, Lund C et al (2013) Stoppers and non-starters of disease-modifying treatment in multiple sclerosis. Acta Neurol Scand 127(2):133–140PubMedCrossRef Grytten N, Aarseth JH, Espeset K, Johnsen GB, Wehus R, Lund C et al (2013) Stoppers and non-starters of disease-modifying treatment in multiple sclerosis. Acta Neurol Scand 127(2):133–140PubMedCrossRef
81.
Zurück zum Zitat Minden SL, Feinstein A, Kalb RC, Miller D, Mohr DC, Patten SB et al (2014) Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 82(2):174–181PubMedPubMedCentralCrossRef Minden SL, Feinstein A, Kalb RC, Miller D, Mohr DC, Patten SB et al (2014) Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 82(2):174–181PubMedPubMedCentralCrossRef
82.
Zurück zum Zitat Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62(6):593–602PubMedCrossRef Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62(6):593–602PubMedCrossRef
83.
Zurück zum Zitat Dahl OP, Stordal E, Lydersen S, Midgard R (2009) Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trondelag County, Norway. Mult Scler. 15(12):1495–1501PubMedCrossRef Dahl OP, Stordal E, Lydersen S, Midgard R (2009) Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trondelag County, Norway. Mult Scler. 15(12):1495–1501PubMedCrossRef
85.
Zurück zum Zitat Beier M, D’Orio V, Spat J, Shuman M, Foley FW (2014) Alcohol and substance use in multiple sclerosis. J Neurol Sci 338(1–2):122–127PubMedCrossRef Beier M, D’Orio V, Spat J, Shuman M, Foley FW (2014) Alcohol and substance use in multiple sclerosis. J Neurol Sci 338(1–2):122–127PubMedCrossRef
86.
Zurück zum Zitat Kirzinger SS, Jones J, Siegwald A, Crush AB (2013) Relationship between disease-modifying therapy and depression in multiple sclerosis. Int J MS Care 15(3):107–112PubMedPubMedCentralCrossRef Kirzinger SS, Jones J, Siegwald A, Crush AB (2013) Relationship between disease-modifying therapy and depression in multiple sclerosis. Int J MS Care 15(3):107–112PubMedPubMedCentralCrossRef
87.
Zurück zum Zitat Kim S, Foley FW, Picone MA, Halper J, Zemon V (2012) Depression levels and interferon treatment in people with multiple sclerosis. Int J MS Care 14(1):10–16PubMedPubMedCentralCrossRef Kim S, Foley FW, Picone MA, Halper J, Zemon V (2012) Depression levels and interferon treatment in people with multiple sclerosis. Int J MS Care 14(1):10–16PubMedPubMedCentralCrossRef
88.
Zurück zum Zitat Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Picconi O et al (2011) Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (Cognitive Impairment in Multiple Sclerosis) study. Mult Scler. 17(8):991–1001PubMedCrossRef Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Picconi O et al (2011) Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (Cognitive Impairment in Multiple Sclerosis) study. Mult Scler. 17(8):991–1001PubMedCrossRef
89.
Zurück zum Zitat Antypa N, Souery D, Tomasini M, Albani D, Fusco F, Mendlewicz J et al (2015) Clinical and genetic factors associated with suicide in mood disorder patients. Eur Arch Psychiatry Clin Neurosci [Epub ahead of print] Antypa N, Souery D, Tomasini M, Albani D, Fusco F, Mendlewicz J et al (2015) Clinical and genetic factors associated with suicide in mood disorder patients. Eur Arch Psychiatry Clin Neurosci [Epub ahead of print]
90.
Zurück zum Zitat Sadovnick AD, Eisen K, Ebers GC, Paty DW (1991) Cause of death in patients attending multiple sclerosis clinics. Neurology [Research Support, Non-U.S. Gov’t] 41(8):1193–1196 Sadovnick AD, Eisen K, Ebers GC, Paty DW (1991) Cause of death in patients attending multiple sclerosis clinics. Neurology [Research Support, Non-U.S. Gov’t] 41(8):1193–1196
91.
Zurück zum Zitat Manouchehrinia A, Tanasescu R, Tench CR, Constantinescu CS (2015) Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2015-310361 Manouchehrinia A, Tanasescu R, Tench CR, Constantinescu CS (2015) Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios. J Neurol Neurosurg Psychiatry. doi:10.​1136/​jnnp-2015-310361
92.
Zurück zum Zitat Scalfari A, Knappertz V, Cutter G, Goodin DS, Ashton R, Ebers GC (2013) Mortality in patients with multiple sclerosis. Neurology [Research Support, Non-U.S. Gov’t Review] 81(2):184–192 Scalfari A, Knappertz V, Cutter G, Goodin DS, Ashton R, Ebers GC (2013) Mortality in patients with multiple sclerosis. Neurology [Research Support, Non-U.S. Gov’t Review] 81(2):184–192
93.
Zurück zum Zitat Pompili M, Forte A, Palermo M, Stefani H, Lamis DA, Serafini G et al (2012) Suicide risk in multiple sclerosis: a systematic review of current literature. J Psychosom Res 73(6):411–417PubMedCrossRef Pompili M, Forte A, Palermo M, Stefani H, Lamis DA, Serafini G et al (2012) Suicide risk in multiple sclerosis: a systematic review of current literature. J Psychosom Res 73(6):411–417PubMedCrossRef
94.
Zurück zum Zitat Stenager EN, Stenager E, Koch-Henriksen N, Bronnum-Hansen H, Hyllested K, Jensen K et al (1992) Suicide and multiple sclerosis: an epidemiological investigation. J Neurol Neurosurg Psychiatry 55(7):542–545PubMedPubMedCentralCrossRef Stenager EN, Stenager E, Koch-Henriksen N, Bronnum-Hansen H, Hyllested K, Jensen K et al (1992) Suicide and multiple sclerosis: an epidemiological investigation. J Neurol Neurosurg Psychiatry 55(7):542–545PubMedPubMedCentralCrossRef
95.
Zurück zum Zitat Dickstein LP, Viguera AC, Nowacki AS, Thompson NR, Griffith SD, Baldessarini RJ et al (2015) Thoughts of death and self-harm in patients with epilepsy or multiple sclerosis in a tertiary care center. Psychosomatics 56(1):44–51PubMedCrossRef Dickstein LP, Viguera AC, Nowacki AS, Thompson NR, Griffith SD, Baldessarini RJ et al (2015) Thoughts of death and self-harm in patients with epilepsy or multiple sclerosis in a tertiary care center. Psychosomatics 56(1):44–51PubMedCrossRef
96.
Zurück zum Zitat Bronnum-Hansen H, Stenager E, Nylev Stenager E, Koch-Henriksen N (2005) Suicide among Danes with multiple sclerosis. J Neurol Neurosurg Psychiatry 76(10):1457–1459PubMedPubMedCentralCrossRef Bronnum-Hansen H, Stenager E, Nylev Stenager E, Koch-Henriksen N (2005) Suicide among Danes with multiple sclerosis. J Neurol Neurosurg Psychiatry 76(10):1457–1459PubMedPubMedCentralCrossRef
97.
Zurück zum Zitat McCabe MP (2002) Relationship functioning and sexuality among people with multiple sclerosis. J Sex Res 39(4):302–309PubMedCrossRef McCabe MP (2002) Relationship functioning and sexuality among people with multiple sclerosis. J Sex Res 39(4):302–309PubMedCrossRef
98.
Zurück zum Zitat Schairer LC, Foley FW, Zemon V, Tyry T, Campagnolo D, Marrie RA et al (2014) The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis. Mult Scler 20(5):610–616PubMedCrossRef Schairer LC, Foley FW, Zemon V, Tyry T, Campagnolo D, Marrie RA et al (2014) The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis. Mult Scler 20(5):610–616PubMedCrossRef
99.
Zurück zum Zitat Jaracz K, Pawlak M, Gorna K, Kolcz B, Woloszyn D, Kozubski W (2010) Quality of life and social support in patients with multiple sclerosis. Neurol Neurochir Pol 44(4):358–365PubMed Jaracz K, Pawlak M, Gorna K, Kolcz B, Woloszyn D, Kozubski W (2010) Quality of life and social support in patients with multiple sclerosis. Neurol Neurochir Pol 44(4):358–365PubMed
100.
Zurück zum Zitat McCabe MP (2004) Exacerbation of symptoms among people with multiple sclerosis: impact on sexuality and relationships over time. Arch Sex Behav 33(6):593–601PubMedCrossRef McCabe MP (2004) Exacerbation of symptoms among people with multiple sclerosis: impact on sexuality and relationships over time. Arch Sex Behav 33(6):593–601PubMedCrossRef
101.
Zurück zum Zitat Foley FW (2011) Assessment and treatment of sexual dysfunction in multiple sclerosis. In: Giesser BS (ed) Primer on multiple sclerosis. Oxford University Press, New York, pp 211–220 Foley FW (2011) Assessment and treatment of sexual dysfunction in multiple sclerosis. In: Giesser BS (ed) Primer on multiple sclerosis. Oxford University Press, New York, pp 211–220
102.
Zurück zum Zitat Bove R, Musallam A, Healy BC, Raghavan K, Glanz BI, Bakshi R et al (2014) Low testosterone is associated with disability in men with multiple sclerosis. Mult Scler [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t] 20(12):1584–1592 Bove R, Musallam A, Healy BC, Raghavan K, Glanz BI, Bakshi R et al (2014) Low testosterone is associated with disability in men with multiple sclerosis. Mult Scler [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t] 20(12):1584–1592
103.
Zurück zum Zitat Bhasin S, Basaria S (2011) Diagnosis and treatment of hypogonadism in men. Best Pract Res Clin Endocrinol Metab [Review] 25(2):251–270CrossRef Bhasin S, Basaria S (2011) Diagnosis and treatment of hypogonadism in men. Best Pract Res Clin Endocrinol Metab [Review] 25(2):251–270CrossRef
104.
Zurück zum Zitat Sicotte NL, Giesser BS, Tandon V, Klutch R, Steiner B, Drain AE et al (2007) Testosterone treatment in multiple sclerosis: a pilot study. Arch Neurol [Clinical Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t] 64(5):683–688 Sicotte NL, Giesser BS, Tandon V, Klutch R, Steiner B, Drain AE et al (2007) Testosterone treatment in multiple sclerosis: a pilot study. Arch Neurol [Clinical Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t] 64(5):683–688
105.
Zurück zum Zitat Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM et al (2010) Adverse events associated with testosterone administration. N Engl J Med [Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, U.S. Gov’t, Non-P.H.S.] 363(2):109–122 Basaria S, Coviello AD, Travison TG, Storer TW, Farwell WR, Jette AM et al (2010) Adverse events associated with testosterone administration. N Engl J Med [Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, U.S. Gov’t, Non-P.H.S.] 363(2):109–122
106.
Zurück zum Zitat Lu E, Zhu F, Zhao Y, van der Kop M, Synnes A, Dahlgren L et al (2014) Birth outcomes in newborns fathered by men with multiple sclerosis exposed to disease-modifying drugs. CNS Drugs 28(5):475–482PubMed Lu E, Zhu F, Zhao Y, van der Kop M, Synnes A, Dahlgren L et al (2014) Birth outcomes in newborns fathered by men with multiple sclerosis exposed to disease-modifying drugs. CNS Drugs 28(5):475–482PubMed
107.
Zurück zum Zitat Pecori C, Giannini M, Portaccio E, Ghezzi A, Hakiki B, Pasto L et al (2014) Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study. BMC Neurol 14:114PubMedPubMedCentralCrossRef Pecori C, Giannini M, Portaccio E, Ghezzi A, Hakiki B, Pasto L et al (2014) Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study. BMC Neurol 14:114PubMedPubMedCentralCrossRef
108.
Zurück zum Zitat Hellwig K, Haghikia A, Gold R (2010) Parenthood and immunomodulation in patients with multiple sclerosis. J Neurol 257(4):580–583PubMedCrossRef Hellwig K, Haghikia A, Gold R (2010) Parenthood and immunomodulation in patients with multiple sclerosis. J Neurol 257(4):580–583PubMedCrossRef
109.
Zurück zum Zitat Kieseier BC, Benamor M (2014) Pregnancy outcomes following maternal and paternal exposure to teriflunomide during treatment for relapsing-remitting multiple sclerosis. Neurol Ther. 3(2):133–138PubMedPubMedCentralCrossRef Kieseier BC, Benamor M (2014) Pregnancy outcomes following maternal and paternal exposure to teriflunomide during treatment for relapsing-remitting multiple sclerosis. Neurol Ther. 3(2):133–138PubMedPubMedCentralCrossRef
110.
Zurück zum Zitat Cavalla P, Rovei V, Masera S, Vercellino M, Massobrio M, Mutani R et al (2006) Fertility in patients with multiple sclerosis: current knowledge and future perspectives. Neurol Sci. 27(4):231–239PubMedCrossRef Cavalla P, Rovei V, Masera S, Vercellino M, Massobrio M, Mutani R et al (2006) Fertility in patients with multiple sclerosis: current knowledge and future perspectives. Neurol Sci. 27(4):231–239PubMedCrossRef
111.
Zurück zum Zitat McCabe MP, Stokes M, McDonald E (2009) Changes in quality of life and coping among people with multiple sclerosis over a 2 year period. Psychol Health Med. 14(1):86–96PubMedCrossRef McCabe MP, Stokes M, McDonald E (2009) Changes in quality of life and coping among people with multiple sclerosis over a 2 year period. Psychol Health Med. 14(1):86–96PubMedCrossRef
112.
Zurück zum Zitat Miller A, Dishon S (2006) Health-related quality of life in multiple sclerosis: the impact of disability, gender and employment status. Qual Life Res 15(2):259–271PubMedCrossRef Miller A, Dishon S (2006) Health-related quality of life in multiple sclerosis: the impact of disability, gender and employment status. Qual Life Res 15(2):259–271PubMedCrossRef
113.
Zurück zum Zitat Janzen W, Turpin KV, Warren SA, Marrie RA, Warren KG (2013) Change in the health-related quality of life of multiple sclerosis patients over 5 years. Int J MS Care 15(1):46–53PubMedPubMedCentralCrossRef Janzen W, Turpin KV, Warren SA, Marrie RA, Warren KG (2013) Change in the health-related quality of life of multiple sclerosis patients over 5 years. Int J MS Care 15(1):46–53PubMedPubMedCentralCrossRef
114.
Zurück zum Zitat van Houtum L, Rijken M, Groenewegen P (2015) Do everyday problems of people with chronic illness interfere with their disease management? BMC Public Health. 15(1):1000PubMedPubMedCentralCrossRef van Houtum L, Rijken M, Groenewegen P (2015) Do everyday problems of people with chronic illness interfere with their disease management? BMC Public Health. 15(1):1000PubMedPubMedCentralCrossRef
115.
Zurück zum Zitat Rosendale N, Josephson SA (2015) The importance of lesbian, gay, bisexual, and transgender health in neurology: what’s in a name? JAMA Neurol 72(8):855–856PubMedCrossRef Rosendale N, Josephson SA (2015) The importance of lesbian, gay, bisexual, and transgender health in neurology: what’s in a name? JAMA Neurol 72(8):855–856PubMedCrossRef
116.
Zurück zum Zitat Jensen MP, Smith AE, Bombardier CH, Yorkston KM, Miro J, Molton IR (2014) Social support, depression, and physical disability: age and diagnostic group effects. Disabil Health J 7(2):164–172PubMedCrossRef Jensen MP, Smith AE, Bombardier CH, Yorkston KM, Miro J, Molton IR (2014) Social support, depression, and physical disability: age and diagnostic group effects. Disabil Health J 7(2):164–172PubMedCrossRef
117.
Zurück zum Zitat Reeves D, Blickem C, Vassilev I, Brooks H, Kennedy A, Richardson G et al (2014) The contribution of social networks to the health and self-management of patients with long-term conditions: a longitudinal study. PLoS ONE [Research Support, Non-U.S. Gov’t] 9(6):e98340 Reeves D, Blickem C, Vassilev I, Brooks H, Kennedy A, Richardson G et al (2014) The contribution of social networks to the health and self-management of patients with long-term conditions: a longitudinal study. PLoS ONE [Research Support, Non-U.S. Gov’t] 9(6):e98340
118.
Zurück zum Zitat Kawachi I, Berkman LF (2001) Social ties and mental health. J Urban Health [Research Support, Non-U.S. Gov’t Review] 78(3):458–467 Kawachi I, Berkman LF (2001) Social ties and mental health. J Urban Health [Research Support, Non-U.S. Gov’t Review] 78(3):458–467
119.
Zurück zum Zitat Glymour MM, Weuve J, Fay ME, Glass T, Berkman LF (2008) Social ties and cognitive recovery after stroke: does social integration promote cognitive resilience? Neuroepidemiology [Comparative Study Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t] 31(1):10–20 Glymour MM, Weuve J, Fay ME, Glass T, Berkman LF (2008) Social ties and cognitive recovery after stroke: does social integration promote cognitive resilience? Neuroepidemiology [Comparative Study Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t] 31(1):10–20
120.
Zurück zum Zitat Loucks EB, Berkman LF, Gruenewald TL, Seeman TE (2006) Relation of social integration to inflammatory marker concentrations in men and women 70 to 79 years. Am J Cardiol [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t] 97(7):1010–1016 Loucks EB, Berkman LF, Gruenewald TL, Seeman TE (2006) Relation of social integration to inflammatory marker concentrations in men and women 70 to 79 years. Am J Cardiol [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t] 97(7):1010–1016
121.
Zurück zum Zitat Starks H, Morris MA, Yorkston KM, Gray RF, Johnson KL (2010) Being in- or out-of-sync: couples’ adaptation to change in multiple sclerosis. Disabil Rehabil [Research Support, N.I.H., Extramural] 32(3):196–206CrossRef Starks H, Morris MA, Yorkston KM, Gray RF, Johnson KL (2010) Being in- or out-of-sync: couples’ adaptation to change in multiple sclerosis. Disabil Rehabil [Research Support, N.I.H., Extramural] 32(3):196–206CrossRef
122.
Zurück zum Zitat Simmons RD, Tribe KL, McDonald EA (2010) Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management. J Neurol [Research Support, Non-U.S. Gov’t] 257(6):926–936 Simmons RD, Tribe KL, McDonald EA (2010) Living with multiple sclerosis: longitudinal changes in employment and the importance of symptom management. J Neurol [Research Support, Non-U.S. Gov’t] 257(6):926–936
123.
Zurück zum Zitat Busche KD, Fisk JD, Murray TJ, Metz LM (2003) Short term predictors of unemployment in multiple sclerosis patients. Can J Neurol Sci 30(2):137–142PubMed Busche KD, Fisk JD, Murray TJ, Metz LM (2003) Short term predictors of unemployment in multiple sclerosis patients. Can J Neurol Sci 30(2):137–142PubMed
124.
Zurück zum Zitat Anaf J, Baum F, Newman L, Ziersch A, Jolley G (2013) The interplay between structure and agency in shaping the mental health consequences of job loss. BMC Public Health [Research Support, Non-U.S. Gov’t] 13:110CrossRef Anaf J, Baum F, Newman L, Ziersch A, Jolley G (2013) The interplay between structure and agency in shaping the mental health consequences of job loss. BMC Public Health [Research Support, Non-U.S. Gov’t] 13:110CrossRef
125.
Zurück zum Zitat Bjorklund O, Soderlund M, Nystrom L, Haggstrom E (2015) Unemployment and health: experiences narrated by young Finnish men. Am J Mens Health. 9(1):76–85PubMedCrossRef Bjorklund O, Soderlund M, Nystrom L, Haggstrom E (2015) Unemployment and health: experiences narrated by young Finnish men. Am J Mens Health. 9(1):76–85PubMedCrossRef
126.
Zurück zum Zitat Razaz N, Tremlett H, Boyce WT, Guhn M, Joseph KS, Marrie RA (2015) Impact of parental multiple sclerosis on early childhood development: a retrospective cohort study. Mult Scler. 21(9):1172–1183PubMedCrossRef Razaz N, Tremlett H, Boyce WT, Guhn M, Joseph KS, Marrie RA (2015) Impact of parental multiple sclerosis on early childhood development: a retrospective cohort study. Mult Scler. 21(9):1172–1183PubMedCrossRef
127.
Zurück zum Zitat Beardslee WR, Versage EM, Gladstone TR (1998) Children of affectively ill parents: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 37(11):1134–1141PubMedCrossRef Beardslee WR, Versage EM, Gladstone TR (1998) Children of affectively ill parents: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 37(11):1134–1141PubMedCrossRef
128.
Zurück zum Zitat Razaz N, Joseph KS, Boyce WT, Guhn M, Forer B, Carruthers R, Marrie RA, Tremlett H (2015) Relationship between parental multiple sclerosis and childhood developmental health. Mult Scler [Epub ahead of print] Razaz N, Joseph KS, Boyce WT, Guhn M, Forer B, Carruthers R, Marrie RA, Tremlett H (2015) Relationship between parental multiple sclerosis and childhood developmental health. Mult Scler [Epub ahead of print]
129.
Metadaten
Titel
Multiple sclerosis in men: management considerations
verfasst von
Riley Bove
Allison McHenry
Kerstin Hellwig
Maria Houtchens
Neda Razaz
Penelope Smyth
Helen Tremlett
A. D. Sadovnick
D. Rintell
Publikationsdatum
02.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 7/2016
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-8005-z

Weitere Artikel der Ausgabe 7/2016

Journal of Neurology 7/2016 Zur Ausgabe

Pioneers in Neurology

Jules Tinel (1879–1952)

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.